XMT-1001 Completed Phase 1 Trials for Non-Small Cell Lung Cancer (NSCLC) / Small Cell Lung Cancer (SCLC) Treatment

Indications	Status	Purpose	Phase
DBCOND0034130 (Non-Small Cell Lung Cancer (NSCLC)) DBCOND0048944 (Small Cell Lung Cancer (SCLC))	Completed	Treatment	1

clinicaltrials.gov Identifier	Title	Drugs
NCT00455052	A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors	XMT-1001 (DB06069)